BTIG announced today that it will hold its annual Biotechnology Conference on Monday, August 7^th and Tuesday, August 8^th, 2023, in New York. The virtual event will host over 80 established and emerging healthcare company management teams for one-on-one investor meetings and thematic panel discussions with industry leaders. Panel themes will include pulmonary hypertension, inflammation and immunology, immuno-oncology, current thoughts on NASH and metabolic diseases, cell therapy advancements, anti-Aβ treatment landscape in Alzheimer’s Disease, antibody drug conjugates, emerging therapeutics for MDD, BPD, and Schizophrenia, and Washington DC’s impact on the Biopharma Industry.

The conference will be hosted by:

• Julian Harrison, BTIG Biotechnology Analyst
• Kaveri Pohlman, PhD, BTIG Biotechnology Analyst
• Thomas Shrader, PhD, CFA, BTIG Biotechnology Analyst
• Justin Zelin, BTIG Biotechnology Analyst
• Bhavin Patel, PharmD, BTIG Healthcare Strategy & Franchise Sales Specialist

“Our team at BTIG has captivated a multitude of leaders in the biotechnology industry to take part in our virtual conference this year,” commented Ryan Serwin, CFA, Director of Research at BTIG. “We are looking forward to hosting these thought leaders and connecting them with investors to examine key market catalysts and trends.”

For more information about the conference, email info@btig.com. Please note that participants must be pre-registered to attend. To access BTIG insights, contact a firm representative or log in to www.btigresearch.com.

About BTIG

BTIG is a global financial services firm specializing in institutional trading, investment banking, research and related brokerage services. With an extensive global footprint and more than 700 employees, BTIG, LLC and its affiliates operate out of 20 cities throughout the U.S., and in Europe, Asia and Australia. BTIG offers execution, expertise and insights for equities, equity derivatives, ETFs and fixed income, currency and commodities. The firm’s core capabilities include global execution, portfolio, electronic and outsource trading, investment banking, prime brokerage, capital introduction, corporate access, research and strategy, commission management and more.

Disclaimer: https://www.btig.com/disclaimer.aspx.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230731735817/en/